121679-20-7

121679-20-7 structure
121679-20-7 structure
  • Name: 3,4-Dihydro Naratriptan
  • Chemical Name: N-methyl-2-[3-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-1H-indol-5-yl]ethanesulfonamide
  • CAS Number: 121679-20-7
  • Molecular Formula: C17H23N3O2S
  • Molecular Weight: 333.45
  • Catalog: Signaling Pathways GPCR/G Protein 5-HT Receptor
  • Create Date: 2018-12-04 11:53:52
  • Modify Date: 2024-01-01 18:36:57
  • 3,4-Dihydro Naratriptan is a serotonin 5-HT1-receptor agonist. 3,4-Dihydro Naratriptan exhibits selective vasoconstrictor activity. 3,4-Dihydro Naratriptan can be used for migraine diseases research[1].

Name N-methyl-2-[3-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-1H-indol-5-yl]ethanesulfonamide
Synonyms 3,4-Didehydronaratriptan
USP naratriptan related compound B free base
Naratriptan Impurity B
UNII-YCR9MR124U
Description 3,4-Dihydro Naratriptan is a serotonin 5-HT1-receptor agonist. 3,4-Dihydro Naratriptan exhibits selective vasoconstrictor activity. 3,4-Dihydro Naratriptan can be used for migraine diseases research[1].
Related Catalog
References

[1]. Sampath Kumar, U., et al. "An investigation into the formation of impurity b during the optimization of naratriptan hydrochloride." Organic Process Research & Development 13.3 (2009): 468-470.

Density 1.26g/cm3
Boiling Point 557.486ºC at 760 mmHg
Molecular Formula C17H23N3O2S
Molecular Weight 333.45
Flash Point 290.957ºC
Exact Mass 333.15100
PSA 73.58000
LogP 3.38810
Vapour Pressure 0mmHg at 25°C
Index of Refraction 1.628

~92%

121679-20-7 structure

121679-20-7

Literature: USV LIMITED Patent: WO2009/118753 A2, 2009 ; Location in patent: Page/Page column 27 ;

~%

121679-20-7 structure

121679-20-7

Literature: WO2011/21000 A2, ;

~%

121679-20-7 structure

121679-20-7

Literature: WO2011/21000 A2, ;

~%

121679-20-7 structure

121679-20-7

Literature: WO2011/21000 A2, ;

~%

121679-20-7 structure

121679-20-7

Literature: WO2011/21000 A2, ;

~%

121679-20-7 structure

121679-20-7

Literature: WO2011/21000 A2, ;